bio pharmaceutic a consideration
TRANSCRIPT
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 1/25
Pertimbangan Biofarmasetika
dalam desain produk obat
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 2/25
• Pertimbangan farmasetika :
Dosis
Bentuk sediaan
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 3/25
Rate limiting steps padaabsorpsi obat
Proses absorpsi sistemik :
1. Desintegrasi produk obat
2. Dissolusi obat dalam lingkungan berair3. Absorpsi melintasi membran masuk ke
sirkulasi sistemik
Rate limiting step merupakan tahapan yglambat dalam satu seri proses kinetika
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 4/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 5/25
Faktor-faktor farmasetika ygmempengaruhi bioavailabilitas obat
Seorang farmasis harus mempertimbangkanhal-hal berikut dalam menetukanmendesain produk obat :
• Tipe produk obat
• Sifat-sifat exipients dalam produk obat
•
Sifat-sifat fisikokimia molekul obat
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 6/25
• Beberapa faktor :
Desintegrasi : merupakan kualiti kontroldalam pembuatan tablet
Dissolusi : merupakan suatu proses dimanaobat melarut dalam pelarutnya.
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 7/25
Persamaan Noyes dan whitney
dC DAK
---- = ------ ( Cs – C )
dt h
dC/dt = laju dissolusi
D = konstanta laju difusi
A = luas permukaan partikel
K = koefisien partisi
Cs = konsentrasi obat dalam lapisan stagnant
C = konsentrasi obat dalam bulk solvent
h = ketebalan lapisan stagnant
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 8/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 9/25
Faktor yg mempengaruhi disolusi
• Sifat fisikokimia obat
luas permukaan, bentuk geometrik partikel
obat, dll• Faktor formulasi yg mempengaruhi
disolusi
excipient, proses manufaktur, dll
• Faktor lingkungan
pH, temperatur, viskositas, dll
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 10/25
Perimbangan biofarmasetika1. Pertimbangan farmakodinamik:
– efek terapeutik yg dituju
– Efek toksik
– Efek samping
2. Pertimbangan obat :
• Sifat fisikokima bahan obat
3. Pertimbangan produk obat :
– Farmakokinetika obat
– Bioavailabilitas obat
– Rute pemberian obat
– Bentuk sediaan yg diinginkan
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 11/25
4. Pertimbangan pasien
– Kecocokan dan penerimaan produk obat
– Harga
5. Pertimbangan manufaktur :
– Harga
– Ketersediaan raw material
– Stabilitas
– Kontrol kualitas
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 12/25
Pertimbangan utama
1. Keamanan2. Efikasi
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 13/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 14/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 15/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 16/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 17/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 18/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 19/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 20/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 21/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 22/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 23/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 24/25
5/14/2018 Bio Pharmaceutic A Consideration - slidepdf.com
http://slidepdf.com/reader/full/bio-pharmaceutic-a-consideration 25/25